Analysis of the key themes driving private equity deal activity reveals that smart hospitals accounted for 7 pharmaceutical deals announced in Q2 2023, worth a total value of $950m. The $800m secondary buy-out Care Hospitals by Blackstone was the industry’s largest disclosed deal. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for Q2 2023 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. Buy the report here.
In volume terms, smart hospitals-related deal activity increased by 250% in Q2 2023 versus the previous quarter and was 600% higher than in Q2 2022.
The top-ranked financial advisors supporting these private equity deals in Q2 2023 were Clearwater International Ltd (France); Lazard; Rothschild & Co with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these private equity deals in Q2 2023 were CMS Legal Services EEIG; Hogan Lovells International; McDermott Will & Emery with 1, 1, 1 deals respectively.
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in Q2 2023 – Thematic Intelligence, buy the report here.